Pfizer BioNtech
Pfizer CEO says Omicron-targeted vaccine to be ready by March
Bourla said Pfizer could be ready to file for U.S. regulatory approval for a redesigned vaccine and launch it as soon as March
Pfizer, BioNTech, Moderna making $1,000 profit every second from COVID vaccines
The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch
Pfizer asks FDA to okay COVID-19 booster shots for all adults
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine
Pfizer says Covid pill 'Paxlovid' 89% effective against severe disease
The results from the clinical trial are so good that Pfizer will stop recruiting new people for the trial, the company said
Pfizer vaccine for kids may not be available until November
The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old
Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Study
Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said
Efficacy of Pfizer/BioNTech Covid vaccine drops to 84 per cent after 6 months
Ongoing follow-up is needed to understand the persistence of the vaccine effect over time
South African firm to make Pfizer vaccine, first in Africa
The move will help address the continent’s desperate need for more vaccine doses amid a recent surge of cases
Pfizer, Moderna covid vaccines don't lower sperm count, study says
The participants were pre-screened to ensure they had no underlying fertility issues
Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study
Pfizer vaccine offered 92 per cent protection against the Alpha variant and 79 per cent against the Delta strain 2 weeks after the 2nd dose